Global Public Offering Fund
Edit

Global Public Offering Fund

https://www.gpofund.com
Last activity: 18.04.2024
The Global Public Offering Fund (GPO Fund) is a growth equity fund investing in founder-led, pre-IPO technology companies that can benefit from access to global capital markets. The fund primarily invests in North American venture-backed, transformative tech-enabled companies that can accelerate growth and market dominance by pursuing global capital investment and a cross-border public listing on a major APAC exchange. The GPO Fund targets investment opportunities that can substantially benefit from: + Going public globally within 12-18 months, + Improved ability to attract and retain talent, + Gaining the support of a global syndicate of investors, + Operational expansion, especially in fast-growing Asia-Pacific, + Simplification of the capital structure and public price discovery, + Ongoing access to capital markets to finance growth, M&A and working capital, + Enhanced credibility, liquidity and flexibility achieved as a publicly listed company.
Mentions
120
Location: United States, New York
Employees: 1-10
Founded date: 2018

Mentions in press and media 120

DateTitleDescriptionSource
18.04.2024PainReform Announces Closing of $4 Million Public Offering-globenewsw...
17.04.2024TScan Therapeutics Announces Pricing of Upsized $150 Million...-globenewsw...
17.04.2024TScan Therapeutics Announces Pricing of Upsized $150 Million...WALTHAM, Mass., April 17, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinic...einpresswi...
16.04.2024Silver Mountain Announces $7.5 Million Public Offering-globenewsw...
16.04.2024TScan Therapeutics Announces Launch of $125 Million Proposed...-globenewsw...
12.04.2024Nurix Therapeutics Announces Pricing of Upsized $175.0 Milli...SAN FRANCISCO, April 11, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX) today anno...einpresswi...
11.04.2024Longeveron Announces Closing of $5.2 Million Public OfferingMIAMI, April 11, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or the “Compa...einpresswi...
11.04.2024Nurix Therapeutics Announces Pricing of Upsized $175.0 Milli...-globenewsw...
11.04.2024Longeveron Announces Closing of $5.2 Million Public Offering-globenewsw...
08.04.2024i-80 Announces C$86 Million Bought Deal Public Offering of U...-globenewsw...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In